Suppr超能文献

RLIM特异性活性报告基因可确定托内-卡尔朔尔综合征中的变异致病性。

RLIM-specific activity reporters define variant pathogenicity in Tonne-Kalscheuer syndrome.

作者信息

Bandi Venkateshwarlu, Rennie Martin, Koch Intisar, Gill Polly, Pacheco Oscar D, Berg Aaron D, Cui Hong, Ward D Isum, Bustos Francisco

机构信息

Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA.

School of Molecular Biosciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

出版信息

HGG Adv. 2025 Jan 9;6(1):100378. doi: 10.1016/j.xhgg.2024.100378. Epub 2024 Oct 31.

Abstract

Tonne-Kalscheuer syndrome (TOKAS; MIM: 300978) is an X-linked recessive disorder with devastating consequences for patients, such as intellectual disability, developmental delay, and multiple congenital abnormalities. TOKAS is associated with hemizygous variants in the RLIM gene, which encodes a RING-type E3 ubiquitin ligase. The current sustained increase in reported RLIM variants of uncertain significance creates an urgent need to develop assays that can screen these variants and experimentally determine their pathogenicity and disease association. Here, we engineered flow cytometry-based RLIM-specific reporters to measure RLIM activity in TOKAS. This paper describes the design and use of RLIM-specific reporters to determine the pathogenicity of a TOKAS RLIM gene variant. Our data demonstrate that RLIM-specific flow cytometry reporters based on either the full length or a degron region of the substrate REX1 measure RLIM activity in cells. Further, we describe the TOKAS variant RLIM p.Asn581Lys and, using reporter assays, determine that it disrupts RLIM catalytic activity. These data reveal how the p.Asn581Lys variant impairs RLIM function and suggests pathogenic mechanisms. The use of RLIM-specific reporters will greatly accelerate the resolution of variants of uncertain significance and disease association in TOKAS.

摘要

托内 - 卡尔舍厄综合征(TOKAS;MIM:300978)是一种X连锁隐性疾病,会给患者带来严重后果,如智力残疾、发育迟缓以及多种先天性异常。TOKAS与RLIM基因的半合子变异有关,该基因编码一种环型E3泛素连接酶。目前,报告的意义不确定的RLIM变异持续增加,迫切需要开发能够筛选这些变异并通过实验确定其致病性和疾病关联性的检测方法。在此,我们构建了基于流式细胞术的RLIM特异性报告基因,以测量TOKAS患者体内的RLIM活性。本文描述了RLIM特异性报告基因的设计和使用,以确定一种TOKAS RLIM基因变异的致病性。我们的数据表明,基于底物REX1的全长或降解区域的RLIM特异性流式细胞术报告基因可测量细胞中的RLIM活性。此外,我们描述了TOKAS变异体RLIM p.Asn581Lys,并通过报告基因检测确定它破坏了RLIM的催化活性。这些数据揭示了p.Asn581Lys变异体如何损害RLIM功能,并提示了致病机制。RLIM特异性报告基因的使用将大大加快TOKAS中意义不确定的变异和疾病关联性的解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1274/11617870/599165a613e7/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验